Document Detail

Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference.
MedLine Citation:
PMID:  23143284     Owner:  NLM     Status:  Publisher    
Data reviewed at the Kyoto Breast Cancer Consensus Conference (KBCCC) showed that preoperative systemic therapy (PST) could optimize surgery through the utilization of information relating to pre- and post-PST tumor stage, therapeutic sensitivity, and treatment-induced changes in the biological characteristics of the tumor. As such, it was noted that the biological characteristics of the tumor, such as hormone receptors, human epidermal growth factor receptor-2, histological grade, cell proliferative activity, mainly defined by the Ki67 labeling index, and the tumor's multi-gene signature, should be considered in the planning of both systemic and local therapy. Furthermore, the timing of axillary sentinel lymph node diagnosis (i.e., before or after the PST) was also noted to be critical in that it may influence the likelihood of axillary preservation, even in node positive cases. In addition, axillary diagnosis with ultrasound and concomitant fine needle aspiration cytology or core needle biopsy (CNB) was reported to contribute to the construction of a treatment algorithm for patient-specific or individualized axillary surgery. Following PST, planning for breast surgery should therefore be based on tumor subtype, tumor volume and extent, therapeutic response to PST, and patient preference. Nomograms for predicting nodal status and drug sensitivity were also recognized as a tool to support decision-making in the selection of surgical treatment. Overall, review of data at the KBCCC showed that PST increases the likelihood of patients receiving localized surgery and individualized treatment regimens.
Masakazu Toi; John R Benson; Eric P Winer; John F Forbes; Gunter von Minckwitz; Mehra Golshan; John F R Robertson; Hironobu Sasano; Bernard F Cole; Louis W C Chow; Mark D Pegram; Wonshik Han; Chiun-Sheng Huang; Tadashi Ikeda; Shotaro Kanao; Eun-Sook Lee; Shinzaburo Noguchi; Shinji Ohno; Ann H Partridge; Roman Rouzier; Mitsuhiro Tozaki; Tomoharu Sugie; Akira Yamauchi; Takashi Inamoto
Related Documents :
24583794 - Estrogen receptor mutations in breast cancer - new focus on an old target.
3820394 - Time lapse videomicroscopic identification of dunning r-3327 adenocarcinoma and normal ...
17373694 - Overexpression of protease-activated receptors-1,-2, and-4 (par-1, -2, and -4) in prost...
24836394 - A phase 1/2 of a combination of cetuximab and taxane for "triple negative" breast cance...
25260534 - Elevated ddx21 regulates c-jun activity and rrna processing in human breast cancers.
10721314 - Differential bore sheath breast biopsy--a pilot study of a new technique.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-11
Journal Detail:
Title:  Breast cancer research and treatment     Volume:  -     ISSN:  1573-7217     ISO Abbreviation:  Breast Cancer Res. Treat.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8111104     Medline TA:  Breast Cancer Res Treat     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Breast Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawara-cho, Sakyo-ku, Kyoto, 606-8507, Japan,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A cost effectiveness study of eribulin versus standard single-agent cytotoxic chemotherapy for women...
Next Document:  The expression of ABC efflux pump, Rv1217c-Rv1218c, and its association with multidrug resistance of...